SLTM Insider Trading Activity and SEC Form 4 Filings
SLTM insider trading summary
No open-market insider purchases or sales of Solta Medical Inc (SLTM) have been reported on SEC Form 4 in the past 12 months.
Latest SLTM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2013 | Douglas W Heigel | VP Operations | Sell | $53K (27,583 @ $1.93) |
| Aug 19, 2013 | Lisa D Parr | VP,Regulatory/Clinical Affairs | Buy | $6K (2,733 @ $2.05) |
| May 30, 2013 | Linda Graebner | Director | Buy | $11K (5,000 @ $2.20) |
| May 30, 2013 | Linda Graebner | Director | Buy | $11K (5,000 @ $2.23) |
| May 17, 2013 | Cathy L McCarthy | Director | Buy | $21K (10,000 @ $2.13) |
| May 10, 2013 | Linda Graebner | Director | Buy | $10K (5,000 @ $1.97) |
| May 6, 2013 | Mark M Sieczkarek | Director | Buy | $261K (150,000 @ $1.74) |
| Feb 22, 2013 | Jeffrey C Nardoci | Vice President of Marketing | Sell | $115K (50,000 @ $2.30) |
| Feb 21, 2012 | Jeffrey C Nardoci | Vice President of Marketing | Sell | $65K (20,984 @ $3.11) |
| Feb 17, 2012 | H Daniel Ferrari | Vice President of Finance | Sell | $31K (10,000 @ $3.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.